DalsnaFinance › IPOs › Nurix Therapeutics Inc › IPO
Nurix Therapeutics, Inc. completed its initial public offering on NASDAQ on July 24, 2020, pricing at $19.00 a share.
| Ticker | NRIX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 24, 2020 |
| Offering price | $19.00 |
| Shares offered | 11,000,000 |
| Total raised | $209M |
Nurix Therapeutics, Inc. sold 11,000,000 shares at $19.00 each on NASDAQ. Multiplied out, that is $209 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $209 million total recorded for the deal.
Nurix Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Nurix Therapeutics, Inc.. This page is general information, not investment advice.